Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Loch JT 3rd"'
Autor:
Murphy-Benenato KE; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Gingipalli L; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Boriack-Sjodin PA; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Martinez-Botella G; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Carcanague D; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Eyermann CJ; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Gowravaram M; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Harang J; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Hale MR; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Ioannidis G; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Jahic H; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Johnstone M; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Kutschke A; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Laganas VA; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Loch JT 3rd; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Miller MD; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Oguto H; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA., Patel SJ; Discovery Sciences, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2015 Nov 15; Vol. 25 (22), pp. 5172-7. Date of Electronic Publication: 2015 Oct 14.
Autor:
Eakin AE; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, Waltham, Massachusetts, USA. Ann.Eakin@astrazeneca.com, Green O, Hales N, Walkup GK, Bist S, Singh A, Mullen G, Bryant J, Embrey K, Gao N, Breeze A, Timms D, Andrews B, Uria-Nickelsen M, Demeritt J, Loch JT 3rd, Hull K, Blodgett A, Illingworth RN, Prince B, Boriack-Sjodin PA, Hauck S, MacPherson LJ, Ni H, Sherer B
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2012 Mar; Vol. 56 (3), pp. 1240-6. Date of Electronic Publication: 2011 Dec 19.
Autor:
Sherer BA; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA. brian.sherer@astrazeneca.com, Hull K, Green O, Basarab G, Hauck S, Hill P, Loch JT 3rd, Mullen G, Bist S, Bryant J, Boriack-Sjodin A, Read J, DeGrace N, Uria-Nickelsen M, Illingworth RN, Eakin AE
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Dec 15; Vol. 21 (24), pp. 7416-20. Date of Electronic Publication: 2011 Oct 12.
Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
Autor:
Stokes SS; Infection Innovative Medicines Unit, AstraZeneca R&D Boston, Waltham, MA 02451, USA. suzanne.stokes@astrazeneca.com, Huynh H, Gowravaram M, Albert R, Cavero-Tomas M, Chen B, Harang J, Loch JT 3rd, Lu M, Mullen GB, Zhao S, Liu CF, Mills SD
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Aug 01; Vol. 21 (15), pp. 4556-60. Date of Electronic Publication: 2011 Jun 12.
Autor:
Wu ES; Department of Chemistry and Biology, Fisons Pharmaceuticals, Rochester, New York 14623, USA., Griffith RC, Loch JT 3rd, Kover A, Murray RJ, Mullen GB, Blosser JC, Machulskis AC, McCreedy SA
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 1995 Apr 28; Vol. 38 (9), pp. 1558-70.
Autor:
Wu ES; Department of Chemistry, Fisons Pharmaceuticals, Rochester, New York 14623., Loch JT 3rd, Toder BH, Borrelli AR, Gawlak D, Radov LA, Gensmantel NP
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 1992 Sep 18; Vol. 35 (19), pp. 3519-25.
Autor:
Wu ES; Department of Organic Chemistry, Pennwalt Corporation, Rochester, New York 14623., Cole TE, Davidson TA, Dailey MA, Doring KG, Fedorchuk M, Loch JT 3rd, Thomas TL, Blosser JC, Borrelli AR, et. al.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 1989 Jan; Vol. 32 (1), pp. 183-92.